Forge Biologics to present at Cell & Gene Meeting on the Mesa

By The Science Advisory Board staff writers

October 11, 2021 -- Forge Biologics will deliver a presentation about its adeno-associated virus gene therapy at the upcoming Cell & Gene Meeting on the Mesa in Carlsbad, CA.

Company CEO and President Timothy Miller, PhD, will discuss the firm's development pipeline on October 12 at 5 p.m. PST. On October 14 at 11 a.m. PST, Miller will participate with a panel of other experts to discuss the topic of dosing and redosing in gene therapy.

Forge Biologics to develop, manufacture GentiBio therapies
GentiBio and Forge Biologics have formed a strategic development and manufacturing partnership to advance GentiBio's immune tolerance platform.
Forge Biologics, Case Western train gene therapy workers
Contract development and manufacturing organization Forge Biologics and Case Western Reserve University in Cleveland announced that they will collaborate...
Forge secures $120M to increase AAV manufacturing capacity
Contract development and manufacturing organization Forge Biologics has closed $120 million in financing to accelerate the expansion of its adeno-associated...

Copyright © 2021

BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter